Tandem Diabetes Care (TNDM) EBT Growth (1y) (2014 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) EBT Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | -29.12% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 26.74% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 35.87% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 53.94% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 12.65% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.89% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -123.12% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 31.69% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 17.94% |
| 10 | Tandem Diabetes Care | 1.26 Bn | 804.14 Mn | 144.78 Mn | 64.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 64.14% |
| Mar 31, 2026 | 83.70% |
| Dec 31, 2025 | 15,660.00% |
| Sep 30, 2025 | -11.18% |
| Jun 30, 2025 | -94.07% |
| Mar 31, 2025 | -208.89% |
| Dec 31, 2024 | 100.10% |
| Sep 30, 2024 | 26.41% |
| Jun 30, 2024 | 14.11% |
| Mar 31, 2024 | 68.02% |
| Dec 31, 2023 | -94.30% |
| Sep 30, 2023 | 35.10% |
| Jun 30, 2023 | -166.38% |
| Mar 31, 2023 | -651.87% |
| Dec 31, 2022 | -245.16% |
| Sep 30, 2022 | -909.66% |
| Jun 30, 2022 | -417.07% |
| Mar 31, 2022 | -216.13% |
| Dec 31, 2021 | -34.85% |
| Sep 30, 2021 | 162.21% |